Related Experiment Video

Updated: Dec 10, 2025

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

6.8K

Emerging functions of PRKDC in the initiation and progression of cancer

Yuting Yin1, Qinglian He1, Yuling Li2

  • 1Department of Pathology, Guangdong Medical University, Dongguan, Guangdong Province, China.

Tumori
|September 2, 2020
PubMed

Insights

DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is crucial for DNA repair and impacts tumor progression. High DNA-PKcs levels correlate with poor prognosis, suggesting it as a therapeutic target for advanced cancers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • DNA-dependent protein kinase catalytic subunit (DNA-PKcs), encoded by the PRKDC gene, is vital for DNA repair pathways.
  • DNA-PKcs is implicated in tumor progression and metastasis, with context-dependent roles in disease.

Purpose of the Study:

  • To review the multifaceted role of DNA-PKcs in various types of tumors.
  • To evaluate the association between DNA-PKcs levels and clinical outcomes in cancer patients.

Main Methods:

  • Literature review of studies investigating DNA-PKcs.
  • Analysis of correlations between DNA-PKcs expression and cancer prognosis.

Main Results:

  • Elevated DNA-PKcs levels are significantly linked to poorer prognosis.
  • High DNA-PKcs expression correlates with increased rates of neoplasm recurrence.
  • DNA-PKcs levels show a direct association with overall survival rates in cancer patients.

Conclusions:

  • DNA-PKcs plays a critical role in cancer, influencing prognosis and survival.
  • The protein kinase, DNA-activated, catalytic polypeptide (PRKDC) offers potential as a therapeutic target.
  • Targeting DNA-PKcs may represent a promising strategy for treating advanced malignancies.
Keywords:
DNA-PKcsPRKDC

More Related Videos

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

2.0K
Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.9K